483
Zimmer, Inc.FDA 483 - Zimmer, Inc. - June 20, 2013
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Zimmer, Inc. in Warsaw, IN, received an FDA Form 483 citing multiple quality system deficiencies. The observations highlight inadequate corrective and preventive actions, unvalidated manufacturing and packaging processes, and failures in design control for their NexGen femoral implants. These issues have led to product quality problems such as implant residue and incompatible implant combinations, with potential for patient harm and revision surgeries.
Open in Dashboard
ID · 0034d134-bf78-4508-8edb-a9b29a73e2aa